Impaired glucose transporter function reduces skeletal muscle glucose uptake, while glucotoxicity and exogenous hyperinsulinemia further diminish peripheral insulin sensitivity in metabolically uncontrolled T1D (44, 45). This evidence concerns the gene INS and Hyperinsulinemia.